Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature.
about
Prostate Radiotherapy in the Era of Advanced Imaging and Precision MedicineThe Utility of Molecular Imaging in Prostate CancerRole of multiparametric magnetic resonance imaging in early detection of prostate cancerMagnetic resonance imaging for prostate cancer: Comparative studies including radical prostatectomy specimens and template transperineal biopsyMultiparametric prostate magnetic resonance imaging in the evaluation of prostate cancerMultiparametric magnetic resonance imaging for prostate cancer: A review and update for urologistsActive surveillance for prostate cancer: current evidence and contemporary state of practiceFocal therapy as primary treatment for localized prostate cancer: definition, needs and future.Identifying Clinically Significant Prostate Cancers using 3-D In Vivo Acoustic Radiation Force Impulse Imaging with Whole-Mount Histology Validation.Restriction spectrum imaging: An evolving imaging biomarker in prostate MRI.Lesion volume predicts prostate cancer risk and aggressiveness: validation of its value alone and matched with prostate imaging reporting and data system score.Utilization of multiparametric prostate magnetic resonance imaging in clinical practice and focal therapy: report from a Delphi consensus projectDiagnostic value and relative weight of sequence-specific magnetic resonance features in characterizing clinically significant prostate cancers.Multi-parametric magnetic resonance imaging as a management decision tool.Pre-biopsy MRI as an adjunct for cancer detection in men with elevated PSA and no previous biopsy.The value of magnetic resonance imaging and ultrasonography (MRI/US)-fusion biopsy platforms in prostate cancer detection: a systematic review.Targeted prostate biopsy and MR-guided therapy for prostate cancer.Development and External Validation of the Korean Prostate Cancer Risk Calculator for High-Grade Prostate Cancer: Comparison with Two Western Risk Calculators in an Asian CohortThe addition of a sagittal image fusion improves the prostate cancer detection in a sensor-based MRI /ultrasound fusion guided targeted biopsyEvaluation of different mathematical models and different b-value ranges of diffusion-weighted imaging in peripheral zone prostate cancer detection using b-value up to 4500 s/mm2The prostate cancer detection rates of CEUS-targeted versus MRI-targeted versus systematic TRUS-guided biopsies in biopsy-naïve men: a prospective, comparative clinical trial using the same patients.New advances in focal therapy for early stage prostate cancer.The University College London/Medical Research Council/National Institute of Health Research-Health Technology Assessment PROMIS Trial: An Update.Difference of opinion - Active surveillance in intermediate risk prostate cancer: is it safe? Opinion: Yes.Biparametric versus multiparametric MRI in the diagnosis of prostate cancer68Ga-PSMA-11 PET/CT for prostate cancer staging and risk stratification in Chinese patients.A urinary biomarker-based risk score correlates with multiparametric MRI for prostate cancer detection.Magnetic resonance imaging for prostate cancer before radical and salvage radiotherapy: What radiation oncologists need to know.Role of mpMRI of the prostate in screening for prostate cancer.A meta-analysis of use of Prostate Imaging Reporting and Data System Version 2 (PI-RADS V2) with multiparametric MR imaging for the detection of prostate cancer.(68)Ga-PSMA-11 PET/CT: the rising star of nuclear medicine in prostate cancer imaging?Recent advances in prostate cancer pathology: Gleason grading and beyond.Prostate cancer risk stratification with magnetic resonance imaging.The current evidence on statin use and prostate cancer prevention: are we there yet?Evaluation of Focal Ablation of Magnetic Resonance Imaging Defined Prostate Cancer Using Magnetic Resonance Imaging Controlled Transurethral Ultrasound Therapy with Prostatectomy as the Reference Standard.Multiparametric magnetic resonance imaging: Current role in prostate cancer management.DCE MRI of prostate cancer.Risk stratification of prostate cancer utilizing apparent diffusion coefficient value and lesion volume on multiparametric MRI.Detection of Clinically Significant Prostate Cancer: Short Dual-Pulse Sequence versus Standard Multiparametric MR Imaging-A Multireader Study.18F Fluorocholine Dynamic Time-of-Flight PET/MR Imaging in Patients with Newly Diagnosed Intermediate- to High-Risk Prostate Cancer: Initial Clinical-Pathologic Comparisons.
P2860
Q26749961-1B7CBC09-2247-4928-9300-61E6469FB8C9Q26764746-A024FB7D-A1FD-4FA1-8B3A-BFDCAF792BCDQ26768765-40920FE0-67D5-4D48-946A-1AA2F7712ECBQ26771360-1BFB9305-3C78-4B53-AE32-8547745AE1AAQ26776478-48E7F34F-38A5-4536-AC29-A34BD4EC27DBQ26801576-E26BBBC5-EE06-4130-8460-007D01C74D42Q28066534-F8A5309C-A9EA-47C5-94C7-6431140CBAAFQ30240753-2DF82135-08B0-465E-AD8F-AF7F7C81BD5BQ30355460-D72181D4-F8C6-44CB-A3E0-9D40DB3DAFABQ31121795-9B30FC6D-8B17-48E5-A42E-E510669B921DQ31127834-194D8728-0358-48B2-A674-7BBCFEA0F362Q33580964-EB9C8BA5-6F15-4853-BB68-0A48F41E3397Q33783620-B3D10ED1-B517-4920-B028-1348E3F94DF9Q33890160-AA994252-B322-4E6D-81AC-D6EF7C2492EEQ33890175-F8C69DF6-A7DB-48FD-A7CE-D2944259E1EAQ35735296-069615F9-4040-43E5-BF3D-8439CAE9E767Q35933229-D350CE95-37CA-4631-BE4E-597C2C53C988Q36238237-C65E1DC5-736E-45BE-943A-5F0EBC799919Q36249431-5BA6BF44-220E-46E8-9C27-DD826833B700Q36281247-6C109028-AE8D-47AB-8816-66CCB55DF29DQ36337051-6EB05828-D50D-4B4D-8C85-B0A10B8284DCQ36411076-7798DC04-9AF1-43B5-9B93-FD8CC905D57FQ36411193-4B886D04-D77D-4D9D-B62B-59EFD96F293CQ37037017-DDFFEF40-81C3-4FDC-9C75-F2BA69546492Q37188694-D825E255-EA16-4EC2-B4D1-3D6B13C9F420Q37707083-611B021A-A497-41BD-8AD4-13CACAF8439BQ38602540-B157530E-31F8-4205-B237-B18737BA7E32Q38636446-F677D8FB-28AB-44D0-B910-C5B6997DF038Q38671170-87F53C76-3EF2-43D7-9224-7E457966E3A9Q38705859-7DECBF70-7A1F-4860-8073-F86557E7993EQ38747415-BCC42511-F3D3-4B96-B145-D4E9BBBA286EQ38779933-C33229BD-FAF1-4ACF-9339-77CE700FFEB8Q38796980-20B564A1-4F5E-418F-A88B-D6D291FBBE15Q38800777-210A4858-C2FF-47E0-9CFD-4823B492E570Q38829383-7EC4C573-F340-4E91-8C37-4F32D5E6DC07Q38835472-D18A58A0-88CA-486F-9CCC-A75FA00541EAQ38837802-82C8D8BE-EC9D-4C4E-80CB-457EF3A25A99Q38842683-4E29FE32-E038-45AB-B367-4E0FEBEB6B55Q38874202-2FDE396F-E23B-4D1F-8503-B6ABE1732B32Q38924757-BF77A3F9-62A6-4BEC-9822-5F22FE75918D
P2860
Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Can Clinically Significant Pro ...... atic Review of the Literature.
@en
type
label
Can Clinically Significant Pro ...... atic Review of the Literature.
@en
prefLabel
Can Clinically Significant Pro ...... atic Review of the Literature.
@en
P2093
P50
P1433
P1476
Can Clinically Significant Pro ...... atic Review of the Literature.
@en
P2093
Alex Kirkham
Geert Villeirs
Gianluca Giannarini
Harriet Thoeny
Jurgen J Fütterer
Pieter De Visschere
Samir S Taneja
P304
P356
10.1016/J.EURURO.2015.01.013
P407
P577
2015-02-02T00:00:00Z